QUANTITATIVE METHODS FOR EVALUATING THE PROCESS ACTIVITY IN THE DIAGNOSIS AND TREATMENT OF T-CELLULAR SKIN LYMPHOMAS
- Authors: Moiochkov V.A1, Kovrigina A.M2, Moiochkov A.V1, Karaulov A.V3, Menshchikova G.V1, Fedorovskaya A.V1, Yefimovich I.V3
-
Affiliations:
- ГУ МОНИКИ им. М.Ф. Владимирского
- ФГБУ Гематологический научный центр Минздрава России
- Первый МГМУ им. И.М. Сеченова Минздрава России
- Issue: Vol 15, No 5 (2012)
- Pages: 4-7
- Section: Articles
- URL: https://journals.rcsi.science/1560-9588/article/view/36723
- DOI: https://doi.org/10.17816/dv36723
- ID: 36723
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
V. A Moiochkov
ГУ МОНИКИ им. М.Ф. Владимирскогод-р мед. наук, проф.
A. M Kovrigina
ФГБУ Гематологический научный центр Минздрава Россиид-р биол. наук
A. V Moiochkov
ГУ МОНИКИ им. М.Ф. Владимирскогод-р мед. наук, проф.
A. V Karaulov
Первый МГМУ им. И.М. Сеченова Минздрава Россиичлен-корр. РАМН, д-р мед. наук, проф.
G. V Menshchikova
ГУ МОНИКИ им. М.Ф. Владимирскогоканд. мед. наук, ассистент
A. V Fedorovskaya
ГУ МОНИКИ им. М.Ф. Владимирского
Email: fedorovskaya84@yandex.ru
аспирант
I. V Yefimovich
Первый МГМУ им. И.М. Сеченова Минздрава России
Email: iraefimov_115@rambler.ru
аспирант
References
- Criscione V.D., Weinstock M.A. Incidence of cutaneous T-cell lymphoma in the United States, 1973—2002. Arch Dermatol. 2007; 143(7): 854—9.
- Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105(10): 3768—85.
- Bunn P.A.Jr., Lamberg S.I. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep. 1979; 63(4): 725—8.
- Kim E.J., Hess S., Richardson S.K., Newton S., Showe L.C., Benoit B.M., et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J. Clin. Invest. 2005; 115(4): 798—812.
- Kim Y., Reddy S., Kim E.J. et al. Romidepsin (depsipeptide, FK228) induces clinically significant responses in treatment-refractory CTCL: further report of an international, multicenter study. Oral presentation at: American Society of Hematology Meeting, Atlanta, Dec 8—11, 2007. ISSN: 0190-9622. doi: 10.1016/j.jaad.2007.01.044.
- Dippel E., Goerdt S., Assaf C., Stein H., Orfanos C.E., et al. Cutaneous T-cell lymphoma severity index and T-cell gene rearrangement. Lancet 1997; 350(9093): 1776—7.
- Olsen E., Vonderheid E., Pimpinelli N., Willemze R., Kim Y., Knobler R., et al.; ISCL/EOrTc. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110(6): 1713—22.
- Stevens S.R., Ke M.S., Parry E.J., Mark J., Cooper K.D. Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas: the severity-weighted assessment tool (SWAT). Arch. Dermatol. 2002; 138(1): 42—8.
- The National Comprehensive Cancer Network mycosis fungoides/Sezary syndrome clinical practice guidelines in oncology (version 3.2008) Available from: URL. Accessed December 4, 2008. http://www.nccn.org.